Table 6 Sensitivity, Specificity, PPV, and NPV at optimal cutoffs with AUC regarding tumor size (1.1–2 cm)
Gene | Sensitivity | Specificity | PPV | NPV | AUC | 95% CI |
|---|---|---|---|---|---|---|
CDO1 | 72% | 88% | 93% | 59% | 0.80 | 0.73–0.88 |
TAC1 | 70% | 70% | 83% | 52% | 0.69 | 0.60–0.79 |
SOX17 | 65% | 93% | 95% | 55% | 0.82 | 0.75–0.89 |
HOXA7 | 61% | 77% | 85% | 48% | 0.72 | 0.63–0.81 |
CDO1, TAC1, SOX17 | 73% | 93% | 96% | 62% | 0.91 | 0.87–0.97 |
CDO1, SOX17, HOXA7 | 74% | 93% | 96% | 63% | 0.92 | 0.87–0.96 |